Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 468Neoplasms 332Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 235Lung Neoplasms 200Prostatic Neoplasms 182Carcinoma, Hepatocellular 175Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 115Uterine Cervical Neoplasms 111Rectal Neoplasms 103Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 80Ovarian Neoplasms 78Neoplasm Metastasis 77Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 64Endometrial Neoplasms 61Small Cell Lung Carcinoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Motor Activity 54Hematologic Neoplasms 54Disease 54Glioma 48

Interventions

Radiotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × HER2-Negative Locally Advanced Breast Cancer × Clear all
NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
170 enrolled
Breast

HER2-Negative Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡